You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: November 28, 2023

Insmed Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INSMED INC, and what generic alternatives to INSMED INC drugs are available?

INSMED INC has one approved drug.

There are twelve US patents protecting INSMED INC drugs.

There are one hundred and seventy-three patent family members on INSMED INC drugs in twenty-nine countries.

Summary for Insmed Inc

International Patents:	173
US Patents:	12
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Insmed Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Insmed Inc	ARIKAYCE KIT	amikacin sulfate	SUSPENSION, LIPOSOMAL;INHALATION	207356-001	Sep 28, 2018		RX	Yes	Yes	9,566,234	⤷ Try a Trial	Y			⤷ Try a Trial
Insmed Inc	ARIKAYCE KIT	amikacin sulfate	SUSPENSION, LIPOSOMAL;INHALATION	207356-001	Sep 28, 2018		RX	Yes	Yes	9,895,385	⤷ Try a Trial				⤷ Try a Trial
Insmed Inc	ARIKAYCE KIT	amikacin sulfate	SUSPENSION, LIPOSOMAL;INHALATION	207356-001	Sep 28, 2018		RX	Yes	Yes	8,679,532	⤷ Try a Trial				⤷ Try a Trial
Insmed Inc	ARIKAYCE KIT	amikacin sulfate	SUSPENSION, LIPOSOMAL;INHALATION	207356-001	Sep 28, 2018		RX	Yes	Yes	11,446,318	⤷ Try a Trial				⤷ Try a Trial
Insmed Inc	ARIKAYCE KIT	amikacin sulfate	SUSPENSION, LIPOSOMAL;INHALATION	207356-001	Sep 28, 2018		RX	Yes	Yes	10,751,355	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Insmed Inc Drugs

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Australia	2013266400	⤷ Try a Trial
Canada	2838111	⤷ Try a Trial
Japan	6646653	⤷ Try a Trial
Japan	5118302	⤷ Try a Trial
Russian Federation	2014151554	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Insmed Inc

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Express Scripts

Dow

AstraZeneca

Harvard Business School

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.